Vitestro
PrivateLast Round
Series B
Mar 10, 2026
Total Funding Raised
$174.93M
Company Overview
Vitestro is a Dutch medical robotics company founded in 2017 that develops and manufactures autonomous blood drawing devices. Its flagship product, Aletta®, combines artificial intelligence, ultrasound-guided 3D reconstruction, and robotic needle insertion to automate the full phlebotomy procedure. The company aims to standardize the blood collection process, improve patient care, and address the global shortage of skilled healthcare personnel. Vitestro received CE marking for its device in mid-2024, enabling commercialization across Europe, and is planning expansion into the U.S. market. The company is backed by venture capital and has raised significant funding to scale its operations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Medical AI, Medical Imaging
Business Model
B2G
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vitestro Comps
Public and private peers based on sector, stage, and business model.
Vitestro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 10, 2026 | ||||
| Early Funding | Apr 30, 2024 | ||||
| Series B | Mar 10, 2024 | ||||
| Series A | Mar 21, 2023 |
Key People
Founding team and executive leadership
Vitestro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifeblood Capital | Early Funding |
| InterVest | Series B |
| European Innovation Council Fund | Early Funding, Series B |
| Puma Venture Capital | Series B |
| Invest-NL | Early Funding, Series B |
| McPike Global Family Office | Series B |
| ROM Utrecht Region | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Expected to grow from 100 to 140 employees this year.
- Mar 10, 2026
Aletta® device to launch in Netherlands in 2027, followed by Denmark and US.
Vitestro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vitestro's valuation, stock price, and market status.
